Publications
Detailed Information
In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model
Cited 31 time in
Web of Science
Cited 35 time in Scopus
- Authors
- Issue Date
- 2007-09-18
- Citation
- FASEB J. 22(2), 488-499
- Keywords
- Animals ; Cell Proliferation/drug effects ; Cells, Cultured ; Disease Models, Animal ; Glioblastoma/*drug therapy/*pathology ; Humans ; Lactic Acid ; Magnetic Resonance Imaging ; Male ; Mice ; Mice, Nude ; Microscopy, Electron, Scanning ; Particle Size ; Peptide Fragments/*pharmacology/*therapeutic use ; Platelet Factor 4/*pharmacology/*therapeutic use ; Polyglycolic Acid ; Polymers ; Time Factors ; Xenograft Model Antitumor Assays ; Microspheres
- Abstract
- The correlation between glioma grade and angiogenesis suggests that antiangiogenic therapies are potentially therapeutically effective for these tumors. However, to achieve tumor suppression, antiangiogenic therapies need to be administered daily using high systemic quantities. We designed a biodegradable polymeric device that overcomes those barriers by providing sustained local delivery of a C-terminal fragment of platelet factor 4 (PF-4/CTF), an antiangiogenic agent. Fluorescent-labeled microspheres composed of poly lactic-coglycolic acid (PLGA) were loaded with rhodamine-labeled PF-4/CTF and formulated to release their contents over time. Fluorescent labeling enabled the correlation between the in vitro to the in vivo kinetic and release studies. PF-4/CTF microspheres were injected into established intracranial human glioma tumors in nude mice. Noninvasive magnetic resonance imaging (MRI) was used to assess the therapeutic response. Tumor size, microvessel density, proliferation, and apoptosis rate were measured by histological analysis. Intracranially, the microspheres were located throughout the tumor bed and continuously released PF-4/CTF during the entire experimental period. MRI and histological studies showed that a single injection of microspheres containing PF-4/CTF caused a 65.2% and 72% reduction in tumor volume, respectively, with a significant decrease in angiogenesis and an increase in apoptosis. Our data demonstrate that polymeric microspheres are an effective therapeutic approach for delivering antiangiogenic agents that result in the inhibition of glioma tumor growth.
- ISSN
- 1530-6860 (Electronic)
- Language
- English
- URI
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17873103
http://www.fasebj.org/cgi/reprint/22/2/488.pdf
https://hdl.handle.net/10371/68353
- Files in This Item:
- There are no files associated with this item.
- Appears in Collections:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.